Blood-Based Diagnostic Assay for λ Light Chain Amyloidosis through Quantification of an Amyloidogenicity-Indicating Neo-Epitope
Xin Jiang(Tsinghua University), Richard Labaudinière(Unknown), Tatiana Prokaeva(Boston University), Vaishali Sanchorawala(Boston Medical Center), Alexander B Jackman, Hannah Flaherty, Yaocheng Li, Eli Muchtar(Mayo Clinic), Jianying Wang(Model Animal Research Center), Angela Dispenzieri(Mayo Clinic), Imani Rogers, Brian Spencer(Boston University)
Cited by 8
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
|Antimicrobial Agents and Chemotherapy|2010|727